“The NHS don’t think PSA is a proper indicator of cancer,” he said. “It is not really accurate for disease of the prostate. So it is not considered cost-effective.”To me, of course, this test would be considered extremely effective if it spotted a cancer in my body early enough to be treated. The determining factor, though, is not the individual’s need to cover every base but NICE’s concern to provide cost-effective medical care to an entire population.